1. Home
  2. OBIO

OBIO

Orchestra BioMed Holdings Inc.

Logo Orchestra BioMed Holdings Inc.

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

as 04-17-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

Founded: 2017 Country:
United States
United States
Employees: N/A City: NEW HOPE
Market Cap: 166.7M IPO Year: N/A
Target Price: $17.00 AVG Volume (30 days): 51.1K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.48 EPS Growth: N/A
52 Week Low/High: $4.25 - $22.91 Next Earning Date: 05-10-2024
Revenue: $2,760,000 Revenue Growth: -21.88%
Revenue Growth (this year): 43.15% Revenue Growth (next year): 0.56%

Share on Social Networks: